MedTrace Logo

Improving Blood Safety and HIV Testing in Brazil

NCT01681420 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11900

Last updated 2018-01-18

No results posted yet for this study

Summary

Conduct a randomized controlled trial (RCT) to test the hypothesis that offering client-centered HIV counseling and testing (HCT) to blood donor candidates will reduce the risk of HIV contamination in the blood supply and also increase appropriate referrals to preventive and care services to persons in need in São Paulo, Brazil.

Conditions

Interventions

BEHAVIORAL

HIV Counseling and Testing

HIV counseling and testing in lieu of blood donation.

BEHAVIORAL

Blood Donation

Blood donation without HIV counseling

Sponsors & Collaborators

  • Vitalant Research Institute

    lead OTHER

Principal Investigators

  • Thelma T. Goncalez, MD, PhD · Vitalant Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-01
Primary Completion
2013-05-31
Completion
2015-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01681420 on ClinicalTrials.gov